Impact of Humalog® insulin on HbA1c values in insulin pump users

被引：0
|
作者：
Garg, SK
Anderson, J
Gerard, L
Chase, P
机构：
来源：
DIABETES | 1999年 / 48卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0977
引用
收藏
页码：A224 / A224
页数：1
相关论文
共 50 条
  • [31] Impact of social deprivation, demographics and centre on HbA1c outcomes with continuous subcutaneous insulin infusion
    Paisley, A. N.
    Beynon, J.
    Fullwood, C.
    Hindle, A.
    Alam, T.
    Urwin, A.
    Chapman, A.
    Morris, J.
    Thabit, H.
    Rutter, M. K.
    Leelarathna, L.
    DIABETIC MEDICINE, 2019, 36 (03) : 383 - 387
  • [32] Impact of Automated Insulin Delivery Systems by Baseline HbA1c in Emerging Adults with Type 1 Diabetes
    Waterman, Lauren A.
    Alonso, Guy T.
    Sakamoto, Casey
    Pyle, Laura
    Forlenza, Gregory P.
    Shah, Viral N.
    Cobry, Erin C.
    DIABETES, 2024, 73
  • [33] Achieving HbA1c targets in patients initiated on insulin - a retrospective audit
    Mettayil, J.
    Kakarla, R.
    Sanders, E.
    DIABETIC MEDICINE, 2007, 24 : 119 - 119
  • [34] The predictive role of HbA1c and previous medications in initiation of insulin treatment
    Demirci, Hakan
    Cinar, Yildirim
    DANISH MEDICAL BULLETIN, 2010, 57 (11)
  • [35] Assessment of glycemic variability in patients with type 1 diabetes whose HbA1c is below 8% under insulin pump
    Barbu, I.
    Raingeard, I.
    Chalancon, A.
    Renard, E.
    Bringer, J.
    Wojtusciszyn, A.
    DIABETES & METABOLISM, 2011, 37 : A106 - A106
  • [36] HBA1C AND INSULIN COVERAGE FOR NEWLY DIAGNOSED HGG PATIENTS IN THE HOSPITAL
    Regis, Patrick
    Cavaliere, Robert
    NEURO-ONCOLOGY, 2022, 24 : 235 - 235
  • [37] Insulin secretion and sensitivity as determinants of HbA1c in type 2 diabetes
    Monnier, L
    Colette, C
    Thuan, JF
    Lapinski, H
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2006, 36 (04) : 231 - 235
  • [38] Improvement in HbA1c with insulin glargine plus insulin lispro in comparison with NPH insulin plus unmodified human insulin in people with type 1 diabetes
    Ashwell, S
    Amiel, S
    Bilous, R
    Heller, S
    Hepburn, D
    Home, P
    DIABETES, 2003, 52 : A442 - A442
  • [39] Insulin detemir reduces hypoglycemic risk at comparable HbA1c values compared to NPH in patients with type 1 diabetes
    Heller, S
    Kim, H
    DIABETES, 2005, 54 : A120 - A120
  • [40] Relationship of baseline HbA1c, HbA1c change and HbA1c target of < 7% with insulin analogues in type 2 diabetes: a meta-analysis of randomised controlled trials
    Giugliano, D.
    Maiorino, M.
    Bellastella, G.
    Chiodini, P.
    Esposito, K.
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2011, 65 (05) : 602 - 612
12345